Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers.

Source:http://linkedlifedata.com/resource/pubmed/id/16179929

Download in:

View as

General Info

PMID
16179929